StockNews.AI
ALVO
StockNews.AI
49 days

Granting of Stock Options and Vesting of Restricted Share Units

1. Alvotech grants stock options to four independent directors at AGM. 2. Each director can purchase 24,784 shares at $9.28 per share. 3. Options vest over three years, starting from the 2025 AGM. 4. The plan aligns board interests with company performance. 5. Directors need to remain on the board for options to be exercisable.

3m saved
Insight
Article

FAQ

Why Bullish?

Aligning director incentives with shareholder interests can boost confidence and stability. Historical cases show that aligning executive pay with performance often leads to better stock performance.

How important is it?

This event directly ties the board's financial interests to the company's performance, likely positively impacting stock value. Board incentives can sway investor confidence dramatically.

Why Long Term?

While initial announcements can affect short-term sentiment, the true impact will manifest as the company's performance unfolds over the vesting period, influencing investor perception in the long run.

Related Companies

ALVO
In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four independent board directors each received a stock option grant allowing the purchase of up to 24,784 Alvotech shares. The aim of the stock option grants is to align the long-term interests of the board members and the Company. The relevant key terms and conditions of the Company´s Equity Incentive Plan approved by Alvotech’s Annual and Extraordinary General Meeting on June 13, 2022 are as follows: The stock option agreements entitle the grantee to purchase Alvotech shares at an exercise price of USD 9.28 per share*.The options are subject to a vesting period over three years with yearly vesting, i.e. one third of the options vest each year starting on the AGM where the stock options were awarded.  The options are only exercisable if the grantee is still a member of the board of Alvotech at the time of vesting. Attached to this announcement are filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) made by the respective four independent board directors of their vested RSUs, in accordance with previous grants. *The exercise price is determined by the opening price of the Company's ordinary shares on the Nasdaq US stock exchange on the date of the grant, in this case on June 25, 2025.  Alvotech Investor RelationsBenedikt Stefansson, VPalvotech.ir@alvotech.com Notification_Managers Transaction_Ann Merchant Notification_Managers Transaction_Hjörleifur Pálsson Notification_Managers Transaction_Lisa Graver Notification_Managers Transaction_Richard Davies

Related News